Daniel Wojdyla

Oct 4, 2024 | onlinelibrary.wiley.com | Nina Nouhravesh |Stephen Greene |Robert M. Clare |Daniel Wojdyla

Supporting Information Filename Description ejhf3458-sup-0001-Supinfo.docxWord 2007 document , 30.3 KB Appendix S1. Supporting Information. References 1, , , , , , et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

May 19, 2024 | jacc.org | Renato D. Lopes |Christopher B Granger |Daniel Wojdyla |William F McIntyre |William Mcintyre

References1. "Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation". Ann Intern Med . 2007;146:857-867. 2. "Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials". Lancet . 2014;383:955-962. 3.

May 15, 2024 | onlinelibrary.wiley.com | Veraprapas Kittipibul |Robert J. Mentz |Robert M. Clare |Daniel Wojdyla

Supporting Information Filename Description ejhf3293-sup-0001-Supinfo.docxWord 2007 document , 215.2 KB Appendix S1. Supporting information. References 1, , , , , , et al.; TRANSFORM-HF Investigators. Effect of torsemide vs furosemide after discharge on all-cause mortality in patients hospitalized with heart failure: The TRANSFORM-HF randomized clinical trial. JAMA 2023; 329: 214–223. https://doi.org/10.1001/jama.2022.23924 2, , , , , , et al.

Mar 1, 2024 | jacc.org | Andrew Wang |John A. Spertus |Daniel Wojdyla |Theodore P. Abraham

References1. "2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines". J Am Coll Cardiol . 2020;76:e159-e240. 2. "Clinical spectrum and management of heart failure in hypertrophic cardiomyopathy". J Am Coll Cardiol HF . 2018;6:353-363. 3.

Jun 26, 2023 | jacc.org | Dhruv Mahtta |Pratik Manandhar |Zachary K. Wegermann |Daniel Wojdyla

JACC Journals › JACC: Interventions › Archives › Vol. 16 No. 12 AbstractBackgroundContemporary data comparing the outcomes of transradial access (TRA) vs transfemoral access (TFA) among patients presenting with acute myocardial infarction and cardiogenic shock (AMI-CS) undergoing percutaneous coronary intervention (PCI) are limited. ObjectivesThis study examines in-hospital outcomes and institutional variation among patients with AMI-CS undergoing TRA-PCI vs TFA-PCI.